FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis

  • Jackson, Aimee (Principal Investigator)
  • Fox, Sonia (Co-Investigator)
  • Craddock, Charles (Researcher)

Project Details

Short titleFEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
StatusActive
Effective start/end date3/12/21 → 30/06/26

Funding

  • CELGENE INTERNATIONAL SARL